title: [Is it advisable to avoid ibuprofen in Kawasaki disease?].
authors.forename: J
authors.initials: J
authors.lastname: Alvarez-Coca González
authors.forename: F J
authors.initials: FJ
authors.lastname: Caballero Mora
authors.forename: B
authors.initials: B
authors.lastname: Alonso Martín
authors.forename: J
authors.initials: J
authors.lastname: Martínez Pérez
mesh_terms: D018712:Analgesics, Non-Narcotic; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D000075202:Contraindications; D006801:Humans; D007052:Ibuprofen; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
chemical_list: D018712:Analgesics, Non-Narcotic; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin; D007052:Ibuprofen